<table className="table"><caption><p>Hormone Regimens in Transgender and Gender Diverse Adults<sup>a</sup></p></caption><thead><tr><th colSpan="2" rowSpan="1"><p>Estrogen-based Regimen (Transfeminine)</p></th></tr></thead><tbody><tr className="group_1-1 row-odd"><td colSpan="2" rowSpan="1"><p>Estrogen<sup>b</sup></p></td></tr><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Oral or sublingual</p></td><td colSpan="1" rowSpan="1"><p></p></td></tr><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Estradiol</p></td><td colSpan="1" rowSpan="1"><p>2.0-6.0 mg/d</p></td></tr><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Transdermal</p></td><td colSpan="1" rowSpan="1"><p></p></td></tr><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Estradiol transdermal patch</p></td><td colSpan="1" rowSpan="1"><p>0.025-0.2 mg/d</p></td></tr><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Estradiol gel various</p></td><td colSpan="1" rowSpan="1"><p>Daily to skin<sup>c</sup></p></td></tr><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Parenteral</p></td><td colSpan="1" rowSpan="1"><p></p></td></tr><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Estradiol valerate or cypionate</p></td><td colSpan="1" rowSpan="1"><p>5-30 mg IM every 2 weeks</p></td></tr><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p></p></td><td colSpan="1" rowSpan="1"><p>2-10 mg IM every week</p></td></tr><tr className="group_1-2 row-even"><td colSpan="2" rowSpan="1"><p>Antiandrogens<sup>b</sup></p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>Spironolactone</p></td><td colSpan="1" rowSpan="1"><p>100-300 mg/d</p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>Cyproterone acetate</p></td><td colSpan="1" rowSpan="1"><p>10 mg/d<sup>d</sup></p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>GnRH agonist</p></td><td colSpan="1" rowSpan="1"><p>3.75-7.50 mg SQ/IM monthly</p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>GnRH agonist depot formulation</p></td><td colSpan="1" rowSpan="1"><p>11.25/22.5 mg SQ/IM 3/6 monthly</p></td></tr><tr><th colSpan="2" rowSpan="1"><p>Testosterone-based Regimen (Transmasculine)</p></th></tr><tr><th colSpan="2" rowSpan="1"><p>Transgender Males</p></th></tr><tr className="group_2-1 row-odd"><td colSpan="2" rowSpan="1"><p>Testosterone<sup>b</sup></p></td></tr><tr className="group_2-1 row-odd"><td colSpan="1" rowSpan="1"><p>Parenteral</p></td><td colSpan="1" rowSpan="1"><p></p></td></tr><tr className="group_2-1 row-odd"><td colSpan="1" rowSpan="1"><p>Testosterone enanthate/cypionate</p></td><td colSpan="1" rowSpan="1"><p>50-100 IM/SQ weekly or 100-200 IM every 2 weeks</p></td></tr><tr className="group_2-1 row-odd"><td colSpan="1" rowSpan="1"><p>Testosterone undecanoate</p></td><td colSpan="1" rowSpan="1"><p>1000 mg IM every 12 weeks or 750 mg IM every 10 weeks</p></td></tr><tr className="group_2-1 row-odd"><td colSpan="1" rowSpan="1"><p>Transdermal testosterone</p></td><td colSpan="1" rowSpan="1"><p></p></td></tr><tr className="group_2-1 row-odd"><td colSpan="1" rowSpan="1"><p>Testosterone gel</p></td><td colSpan="1" rowSpan="1"><p>50-100 mg/d</p></td></tr><tr className="group_2-1 row-odd"><td colSpan="1" rowSpan="1"><p>Testosterone transdermal patch</p></td><td colSpan="1" rowSpan="1"><p>2.5-7.5 mg/d</p></td></tr></tbody></table>